Chlorine in PDB, part 346 (files: 13801-13840),
PDB 5pb6-5qa6
Experimental structures of coordination spheres of Chlorine (Cl) in bioorganic
molecules from X-Ray and NMR experiments. Coordination spheres were calculated with 5.0 Angstroms radius
around Chlorine atoms. PDB files: 13801-13840 (PDB 5pb6-5qa6).
-
5pb6 (Cl: 3) - Crystal Structure of Factor Viia in Complex with N-[[3-[5-Hydroxy-4- (1H-Pyrrolo[3,2-C]Pyridin-2-Yl)Pyrazol-1-Yl]Phenyl]Methyl]Pentanamide
Other atoms:
Ca (1);
-
5phl (Cl: 1) - Pandda Analysis Group Deposition -- Crystal Structure of JMJD2D in Complex with N09506A
Other atoms:
Ni (1);
Zn (1);
-
5pny (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of BRD1 in Complex with N10174A
Other atoms:
Na (1);
-
5pot (Cl: 1) - Pandda Analysis Group Deposition -- Crystal Structure of BRD1 in Complex with N10931A
Other atoms:
Na (1);
-
5prc (Cl: 1) - Photosynthetic Reaction Center From Rhodopseudomonas Viridis (Atrazine Complex)
Other atoms:
Mg (4);
Fe (5);
-
5pwc (Cl: 5) - Pandda Analysis Group Deposition -- Crystal Structure of SP100 in Complex with E48115B
Other atoms:
Zn (4);
-
5pwd (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of SP100 in Complex with N09600B
Other atoms:
Zn (4);
-
5pzr (Cl: 4) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(3-Chlorophenyl)Sulfonyl-3-[3-[3-[(3-Chlorophenyl) Sulfonylcarbamoylamino]Propoxy]Propyl]Urea
-
5pzs (Cl: 4) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(3-Chlorophenyl)Sulfonyl-3-[6-[(3-Chlorophenyl) Sulfonylcarbamoylamino]Hexyl]Urea
-
5pzv (Cl: 4) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(4-Bromopyridin-2-Yl)-3-(4-Chlorophenyl)Sulfonylurea
Other atoms:
Br (4);
-
5pzw (Cl: 4) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(3-Chlorophenyl)Sulfonyl-3-[5-[(3-Chlorophenyl) Sulfonylcarbamoylamino]Pentyl]Urea
-
5pzy (Cl: 8) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(5-Bromo-1,3-Thiazol-2-Yl)-3-(2-Chlorophenyl)Sulfonylurea
Other atoms:
Br (8);
-
5pzz (Cl: 16) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(5-Bromo-1,3-Thiazol-2-Yl)-3-(3,4-Dichlorophenyl)Sulfonylurea
Other atoms:
Br (8);
-
5q01 (Cl: 16) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(5-Bromo-1,3-Thiazol-2-Yl)-3-[4-(4,5-Dichloro-2-Methylpyrazol-3- Yl)Oxyphenyl]Sulfonylurea
Other atoms:
Br (8);
-
5q04 (Cl: 8) - Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 1-(4-Bromo-5-Chlorothiophen-2-Yl)Sulfonyl-3-(5-Bromo-1,3-Thiazol-2- Yl)Urea
Other atoms:
Br (16);
-
5q0d (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl [(7S)-7-({(2E)-3-[5- Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-2-Oxo-1,2,3,4, 5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecin-14- Yl]Carbamate
-
5q0e (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl [(4S,8S)-8-({(2E)-3- [5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-4-Methyl-2- Oxo-1,3,4,5,6,7,8,10-Octahydro-2H-12,9-(Azeno)-1,10- Benzodiazacyclotetradecin-15-Yl]Carbamate
-
5q0f (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl [(4R,5E,8S)-8-({(2E)- 3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-4-Methyl- 2-Oxo-1,3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10- Benzodiazacyclotetradecin-15-Yl]Carbamate
-
5q0g (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl [(3R,7S)-7-({(2E)-3- [5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-3-Ethyl-2- Oxo-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9- Benzodiazacyclotridecin-14-Yl]Carbamate
-
5q0h (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl [(4R,5E,8S)-11-Chloro- 8-[(2,6-Difluoro-4-Methylbenzene-1-Carbonyl)Amino]-4-Methyl-2-Oxo-1, 3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin- 15-Yl]Carbamate
Other atoms:
F (2);
-
5q0n (Cl: 4) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (4);
-
5q0o (Cl: 1) - Ligand Binding to Farnesoid-X-Receptor
-
5q0p (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (4);
-
5q0s (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (4);
-
5q0u (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (4);
-
5q0v (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (6);
-
5q0w (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
Br (1);
-
5q0x (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
-
5q10 (Cl: 1) - Ligand Binding to Farnesoid-X-Receptor
-
5q11 (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
-
5q13 (Cl: 4) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (2);
-
5q14 (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (6);
-
5q16 (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (2);
-
5q1d (Cl: 2) - Ligand Binding to Farnesoid-X-Receptor
Other atoms:
F (4);
-
5q1i (Cl: 1) - Ligand Binding to Farnesoid-X-Receptor
-
5q1z (Cl: 1) - Pandda Analysis Group Deposition -- Crystal Structure of DCLRE1A in Complex with FMOPL000150A
Other atoms:
Ni (1);
-
5q29 (Cl: 1) - Pandda Analysis Group Deposition -- Crystal Structure of DCLRE1A in Complex with FMOPL000058A
Other atoms:
Ni (1);
-
5qa4 (Cl: 3) - Oxa-48 in Complex with Compound 3A
-
5qa5 (Cl: 3) - Oxa-48 in Complex with Compound 3B
-
5qa6 (Cl: 2) - Oxa-48 in Complex with Compound 4A
Page generated: Mon Aug 4 20:12:44 2025
|
